Skip to main content
Naomi Ko, MD, Oncology, Boston, MA

Naomi Ko MD MPH (She/her)

Breast Cancer


Mary Beth and Chris Gordon Fellow, Radcliffe Institute of Advanced Study, Harvard University. Section Chief Breast Medical Oncology, NYU Langone, New York, NY. Associate Professor of Medicine, NYU Grossman School of Medicine, New York, NY.

Join to View Full Profile
  • 830 Harrison AveBoston, MA 02118

  • Phone+1 617-638-6428

  • Fax+1 617-638-5756

Dr. Ko is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Naomi Ko is a medical oncologist based in New York, NY. She completed her fellowship in Hematology and Medical Oncology at Boston University Medical Center and her residency in Internal Medicine at Brigham and Women's Hospital after graduating from Johns Hopkins University School of Medicine in 2006. Dr. Ko has contributed to the medical field with her publications in several respected journals, most commonly focusing on the topic of breast cancer in varying demographics. She's also involved in clinical trials, and translational research. In 2025-26, she is the Mary Beth and Chris Gordon fellow at the Harvard Radcliffe Institute.

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterFellowship, Hematology and Medical Oncology, 2010 - 2013
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2006 - 2009
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 2006

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2009 - 2027
  • NY State Medical License
    NY State Medical License 2025 - 2027
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Insurance status and racial disparities in detection of early-stage breast cancer. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Working together in cancer care: An academic community partnership for a diverse patient population. 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • NYU Langone Perlmutter Cancer Center Names Renowned Medical Oncologist as Section Chief & Disease Management Group Leader for Breast Cancer Medical Oncology
    NYU Langone Perlmutter Cancer Center Names Renowned Medical Oncologist as Section Chief & Disease Management Group Leader for Breast Cancer Medical OncologyMay 23rd, 2025
  • Your Breast Cancer Risk May Have Just Changed – What to Know
    Your Breast Cancer Risk May Have Just Changed – What to KnowApril 1st, 2025
  • HMN 2025: Aggressive Breast Cancer Linked to Obesity-Driven Diabetes
    HMN 2025: Aggressive Breast Cancer Linked to Obesity-Driven DiabetesMarch 9th, 2025

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: